Establishment Labs (ESTA) Competitors $41.23 -1.25 (-2.94%) Closing price 04:00 PM EasternExtended Trading$41.28 +0.05 (+0.12%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ESTA vs. SLNO, IRTC, INSP, TMDX, NVST, PRCT, WRBY, LIVN, EYE, and LMATShould you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), Inspire Medical Systems (INSP), TransMedics Group (TMDX), Envista (NVST), PROCEPT BioRobotics (PRCT), Warby Parker (WRBY), LivaNova (LIVN), National Vision (EYE), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry. Establishment Labs vs. Its Competitors Soleno Therapeutics iRhythm Technologies Inspire Medical Systems TransMedics Group Envista PROCEPT BioRobotics Warby Parker LivaNova National Vision LeMaitre Vascular Establishment Labs (NASDAQ:ESTA) and Soleno Therapeutics (NASDAQ:SLNO) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk. Does the media refer more to ESTA or SLNO? In the previous week, Soleno Therapeutics had 1 more articles in the media than Establishment Labs. MarketBeat recorded 9 mentions for Soleno Therapeutics and 8 mentions for Establishment Labs. Soleno Therapeutics' average media sentiment score of 1.34 beat Establishment Labs' score of 0.78 indicating that Soleno Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Soleno Therapeutics 5 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals have more ownership in ESTA or SLNO? 72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 97.4% of Soleno Therapeutics shares are held by institutional investors. 11.4% of Establishment Labs shares are held by insiders. Comparatively, 6.4% of Soleno Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has preferable valuation and earnings, ESTA or SLNO? Establishment Labs has higher revenue and earnings than Soleno Therapeutics. Soleno Therapeutics is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEstablishment Labs$166.02M7.18-$84.60M-$3.10-13.30Soleno TherapeuticsN/AN/A-$175.85M-$4.62-18.18 Is ESTA or SLNO more profitable? Soleno Therapeutics has a net margin of 0.00% compared to Establishment Labs' net margin of -52.34%. Soleno Therapeutics' return on equity of -77.52% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets Establishment Labs-52.34% -196.25% -26.64% Soleno Therapeutics N/A -77.52%-63.44% Which has more volatility & risk, ESTA or SLNO? Establishment Labs has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, Soleno Therapeutics has a beta of -2.63, indicating that its share price is 363% less volatile than the S&P 500. Do analysts rate ESTA or SLNO? Establishment Labs currently has a consensus target price of $54.83, suggesting a potential upside of 32.99%. Soleno Therapeutics has a consensus target price of $108.70, suggesting a potential upside of 29.45%. Given Establishment Labs' higher probable upside, research analysts plainly believe Establishment Labs is more favorable than Soleno Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Soleno Therapeutics 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 SummaryEstablishment Labs and Soleno Therapeutics tied by winning 8 of the 16 factors compared between the two stocks. Get Establishment Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ESTA vs. The Competition Export to ExcelMetricEstablishment LabsMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.23B$7.31B$5.70B$9.56BDividend YieldN/A2.82%4.71%4.06%P/E Ratio-13.3024.5928.1919.94Price / Sales7.1835.42461.9396.03Price / CashN/A26.9436.3258.72Price / Book21.708.858.295.77Net Income-$84.60M$239.96M$3.25B$259.21M7 Day Performance-5.15%-3.29%0.21%-0.80%1 Month Performance0.73%1.88%8.71%9.81%1 Year Performance-12.39%10.48%32.76%14.37% Establishment Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ESTAEstablishment Labs2.1028 of 5 stars$41.23-2.9%$54.83+33.0%-11.9%$1.23B$166.02M-13.301,018Analyst UpgradeSLNOSoleno Therapeutics4.3452 of 5 stars$86.97-0.3%$108.70+25.0%+75.8%$4.39BN/A-18.8230Positive NewsAnalyst UpgradeIRTCiRhythm Technologies1.0084 of 5 stars$135.52-0.5%$137.30+1.3%+55.2%$4.35B$591.84M-43.162,000Upcoming EarningsINSPInspire Medical Systems4.8593 of 5 stars$125.13-1.3%$210.27+68.0%+3.9%$3.74B$802.80M57.661,246Positive NewsUpcoming EarningsAnalyst DowngradeTMDXTransMedics Group1.895 of 5 stars$103.61-5.7%$129.88+25.3%-25.1%$3.72B$441.54M76.18210Positive NewsUpcoming EarningsNVSTEnvista3.3461 of 5 stars$19.47-0.2%$20.23+3.9%+27.1%$3.31B$2.51B-2.9812,300Positive NewsUpcoming EarningsAnalyst ForecastPRCTPROCEPT BioRobotics2.6918 of 5 stars$57.05-2.2%$84.13+47.5%-12.6%$3.23B$224.50M-33.56430Upcoming EarningsWRBYWarby Parker2.8961 of 5 stars$24.35+1.7%$22.88-6.0%+45.9%$2.50B$771.32M-202.903,780LIVNLivaNova3.2836 of 5 stars$42.35+0.9%$59.29+40.0%-18.9%$2.29B$1.25B-10.352,900Positive NewsEYENational Vision2.6448 of 5 stars$25.31+0.9%$22.10-12.7%+70.0%$1.98B$1.82B-76.6913,411Analyst DowngradeLMATLeMaitre Vascular2.2308 of 5 stars$79.82+0.1%$97.83+22.6%-3.9%$1.80B$219.86M40.31490Upcoming Earnings Related Companies and Tools Related Companies Soleno Therapeutics Alternatives iRhythm Technologies Alternatives Inspire Medical Systems Alternatives TransMedics Group Alternatives Envista Alternatives PROCEPT BioRobotics Alternatives Warby Parker Alternatives LivaNova Alternatives National Vision Alternatives LeMaitre Vascular Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ESTA) was last updated on 7/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ESTA Stock Alerts